Fresenius Kabi introduces Heparin Sodium in freeflex containers

Fresenius Kabi in Lake Zurich said it has introduced four new presentations of Heparin Sodium in the company's proprietary ready-to-administer freeflex containers.

Fresenius Kabi introduced the advanced IV-container technology in the U.S. in 2013, and has been expanding its portfolio of convenient, ready-to-administer medicines in non-DEHP bags as well as in pre filled syringes.

Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.

"Clinicians continue to look for convenient, ready-to-administer products to help minimize drug errors and assure patient safety," said John Ducker, president and CEO of Fresenius Kabi USA. "We remain focused on meeting these needs by expanding the number of products we offer in both freeflex bags and pre filled syringes. With this most recent offering we're also proud to offer the most comprehensive portfolio of Heparin Sodium in the U.S."

Fresenius Kabi offers Heparin Sodium in 11 vial presentations and one pre filled syringe presentation, in addition to the new freeflex offerings

Heparin Sodium is contraindicated in patients with history of Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis, known hypersensitivity to heparin or pork products, those whom suitable blood coagulation tests cannot be performed at appropriate intervals, and patients with uncontrolled bleeding states, except when this is due to disseminated intravascular coagulation.